209 related articles for article (PubMed ID: 29597166)
21. Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy.
Posner GH; Paik IH; Sur S; McRiner AJ; Borstnik K; Xie S; Shapiro TA
J Med Chem; 2003 Mar; 46(6):1060-5. PubMed ID: 12620083
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of extraordinarily potent C-10 carba artemisinin dimers against P. falciparum malaria parasites and HL-60 cancer cells.
Chadwick J; Mercer AE; Park BK; Cosstick R; O'Neill PM
Bioorg Med Chem; 2009 Feb; 17(3):1325-38. PubMed ID: 19136263
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and biological evaluation of artemisinin-indoloquinoline hybrids as potent antiproliferative agents.
Wang L; Świtalska M; Wang N; Du ZJ; Fukumoto Y; Diep NK; Kiguchi R; Nokami J; Wietrzyk J; Inokuchi T
Molecules; 2014 Nov; 19(11):19021-35. PubMed ID: 25412047
[TBL] [Abstract][Full Text] [Related]
24. Artemisinin-derived hybrids and their anticancer activity.
Gao F; Sun Z; Kong F; Xiao J
Eur J Med Chem; 2020 Feb; 188():112044. PubMed ID: 31945642
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological activities of artemisinin-piperazine-dithiocarbamate derivatives.
Yu JY; Li XQ; Wei MX
Eur J Med Chem; 2019 May; 169():21-28. PubMed ID: 30852384
[TBL] [Abstract][Full Text] [Related]
26. Discovery of novel artemisinin-sulfonamidehybrids as potential carbonicanhydraseIX inhibitors with improved antiproliferative activities.
An R; Lin B; Zhao S; Cao C; Wang Y; Cheng X; Liu Y; Guo M; Xu H; Wang Y; Hou Z; Guo C
Bioorg Chem; 2020 Nov; 104():104347. PubMed ID: 33142414
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic Potentials and Mechanisms of Artemisinin and its Derivatives for Tumorigenesis and Metastasis.
Li Y; Zhou X; Liu J; Yuan X; He Q
Anticancer Agents Med Chem; 2020; 20(5):520-535. PubMed ID: 31958040
[TBL] [Abstract][Full Text] [Related]
28. Stereoselective Access to Antimelanoma Agents by Hybridization and Dimerization of Dihydroartemisinin and Artesunic acid.
Botta L; Cesarini S; Zippilli C; Filippi S; Bizzarri BM; Baratto MC; Pogni R; Saladino R
ChemMedChem; 2021 Jul; 16(14):2270-2277. PubMed ID: 33792170
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of nοvel artemisinin dimers with polyamine linkers and evaluation of their potential as anticancer agents.
Magoulas GE; Tsigkou T; Skondra L; Lamprou M; Tsoukala P; Kokkinogouli V; Pantazaka E; Papaioannou D; Athanassopoulos CM; Papadimitriou E
Bioorg Med Chem; 2017 Jul; 25(14):3756-3767. PubMed ID: 28549888
[TBL] [Abstract][Full Text] [Related]
30. Antimalarial, antiproliferative, and antitumor activities of artemisinin-derived, chemically robust, trioxane dimers.
Posner GH; Ploypradith P; Parker MH; O'Dowd H; Woo SH; Northrop J; Krasavin M; Dolan P; Kensler TW; Xie S; Shapiro TA
J Med Chem; 1999 Oct; 42(21):4275-80. PubMed ID: 10543871
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of Tamoxifen-Artemisinin and Estrogen-Artemisinin Hybrids Highly Potent Against Breast and Prostate Cancer.
Fröhlich T; Mai C; Bogautdinov RP; Morozkina SN; Shavva AG; Friedrich O; Gilbert DF; Tsogoeva SB
ChemMedChem; 2020 Aug; 15(15):1473-1479. PubMed ID: 32374071
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and cytotoxicity of novel artemisinin derivatives containing sulfur atoms.
Xu CC; Wu JJ; Xu T; Yao CH; Yu BY; Liu JH
Eur J Med Chem; 2016 Nov; 123():763-768. PubMed ID: 27537924
[TBL] [Abstract][Full Text] [Related]
33. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
34. Activation of Intrinsic Apoptosis and G1 Cell Cycle Arrest by a Triazole Precursor, N-(4-chlorophenyl)-2-(4-(3,4,5-trimethoxybenzyloxy)benzoyl)-hydrazinecarbothioamide in Breast Cancer Cell Line.
Arulnathan SB; Leong KH; Ariffin A; Kareem HS; Cheah KKH
Anticancer Agents Med Chem; 2020; 20(9):1072-1086. PubMed ID: 32188392
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and cytotoxic activity of new artemisinin hybrid molecules against human leukemia cells.
Letis AS; Seo EJ; Nikolaropoulos SS; Efferth T; Giannis A; Fousteris MA
Bioorg Med Chem; 2017 Jul; 25(13):3357-3367. PubMed ID: 28456567
[TBL] [Abstract][Full Text] [Related]
36. 2-((1-Phenyl-1H-1,2,3-triazol-4-yl)methyl)-2-azabicyclo[3.2.1]octan-3-one derivatives: Simplification and modification of aconitine scaffold for the discovery of novel anticancer agents.
Zhang Y; Zhang TJ; Li XY; Liang JW; Tu S; Xu HL; Xue WH; Qian XH; Zhang ZH; Zhang X; Meng FH
Eur J Med Chem; 2021 Jan; 210():112988. PubMed ID: 33189438
[TBL] [Abstract][Full Text] [Related]
37. Discovery of artemisinin-glycolipid hybrids as anti-oral cancer agents.
Ricci J; Kim M; Chung WY; Park KK; Jung M
Chem Pharm Bull (Tokyo); 2011; 59(12):1471-5. PubMed ID: 22130368
[TBL] [Abstract][Full Text] [Related]
38. Recent advances in artemisinin and its derivatives as antimalarial and antitumor agents.
Jung M; Lee K; Kim H; Park M
Curr Med Chem; 2004 May; 11(10):1265-84. PubMed ID: 15134519
[TBL] [Abstract][Full Text] [Related]
39. Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents.
Chaturvedi D; Goswami A; Saikia PP; Barua NC; Rao PG
Chem Soc Rev; 2010 Feb; 39(2):435-54. PubMed ID: 20111769
[TBL] [Abstract][Full Text] [Related]
40. Mechanism-Guided Design and Synthesis of a Mitochondria-Targeting Artemisinin Analogue with Enhanced Anticancer Activity.
Zhang CJ; Wang J; Zhang J; Lee YM; Feng G; Lim TK; Shen HM; Lin Q; Liu B
Angew Chem Int Ed Engl; 2016 Oct; 55(44):13770-13774. PubMed ID: 27709833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
